All Stories

  1. Classification of unsequenced Mycobacterium tuberculosis strains in a high-burden setting using a pairwise logistic regression approach
  2. Understanding tuberculosis transmission and progression: A prospective cohort study of index cases and close contacts in Moldova
  3. Classification of unsequenced Mycobacterium tuberculosis strains in a high-burden setting using a pairwise logistic regression approach
  4. Author Correction: The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova
  5. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis
  6. Comparison of QTc interval changes in drug-resistant tuberculosis patients on delamanid-containing regimens versus shorter treatment regimens
  7. A new method for detecting mixed Mycobacterium tuberculosis infection and reconstructing constituent strains provides insights into transmission
  8. The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova
  9. Identifying local foci of tuberculosis transmission in Moldova using a spatial multinomial logistic regression model
  10. Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection
  11. Predicting stringent QuantiFERON-TB Gold Plus conversions in contacts of tuberculosis patients
  12. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis
  13. Geographical analysis and evaluation of M. tuberculosis genome sequencing at the national level
  14. Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis
  15. Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods
  16. Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis
  17. Integrating landmark modeling framework and machine learning algorithms for dynamic prediction of tuberculosis treatment outcomes
  18. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study
  19. Benchmarking the empirical accuracy of short-read sequencing across the M. tuberculosis genome
  20. Emergence of bedaquiline-resistance in a high-burden country of tuberculosis
  21. Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova
  22. Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study
  23. Phylogeography and transmission of M. tuberculosis in Moldova
  24. Clinical evaluation of the Xpert MTB/XDR assay for rapid detection of isoniazid, fluoroquinolone, ethionamide and second-line drug resistance: A cross-sectional multicentre diagnostic accuracy study
  25. Genomic sequence characteristics and the empiric accuracy of short-read sequencing
  26. Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
  27. Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova
  28. Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study (Preprint)
  29. Molecular Detection of Mycobacterium tuberculosis in Oral Mucosa from Patients with Presumptive Tuberculosis
  30. Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country
  31. Automated high-throughput digital fluorescence microscopy for TB diagnosis
  32. A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status
  33. A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.
  34. Prediction of multiple drug resistant pulmonary tuberculosis against drug sensitive pulmonary tuberculosis by CT nodular consolidation sign
  35. Assessing tuberculosis control priorities in high-burden settings: a modelling approach
  36. Failing treatment of multidrug-resistant tuberculosis: a matter of definition
  37. Building a tuberculosis-free world: The Lancet Commission on tuberculosis
  38. Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis
  39. Beyond the SNP Threshold: Identifying Outbreak Clusters Using Inferred Transmissions
  40. Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries
  41. Beyond the SNP threshold: identifying outbreak clusters using inferred transmissions
  42. Cost analysis of rapid diagnostics for drug-resistant tuberculosis
  43. Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria
  44. Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure
  45. High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova
  46. Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of thekatG315T mutation
  47. The TB Portals: database for M/XDR TB
  48. Treatment outcomes of MDR-TB and HIV co-infection in Europe
  49. FATE: the new partnership to Fight Against TB in Central and Eastern Europe
  50. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
  51. MDR-TB in Eastern Europe in the era of the TB elimination action framework
  52. Armed conflict and population displacement as drivers of the evolution and dispersal of Mycobacterium tuberculosis
  53. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
  54. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
  55. Urgent need to rethink treatment outcome definitions in tuberculosis
  56. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis
  57. Errata
  58. Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study
  59. A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis
  60. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape
  61. In reply
  62. MTBDRplusand MTBDRslAssays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis
  63. Nosocomial transmission of multidrug-resistant tuberculosis
  64. Beyond multidrug-resistant tuberculosis in Europe: a TBNET study
  65. Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations
  66. Out-patient MDR-TB care in Moldova
  67. Transmission ofmycobacterium tuberculosisUral 163-15 lineage causing multidrug-resistant tuberculosis among hospitalized patients
  68. Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis
  69. Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing
  70. Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates
  71. Combined Antigen-Specific Interferon-γ and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection
  72. Multidrug-Resistant Tuberculosis in Europe, 2010–2011
  73. Prognostic significance of novel katG mutations in Mycobacterium tuberculosis
  74. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage
  75. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates
  76. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis
  77. Evaluation of Pyrosequencing for Detecting Extensively Drug-Resistant Mycobacterium tuberculosis among Clinical Isolates from Four High-Burden Countries
  78. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
  79. High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
  80. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay
  81. Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations
  82. Publisher's Expression of Concern: Geographical Differences Associated with SNPs in Nine Gene Targets among Resistant Clinical Isolates of Mycobacterium tuberculosis
  83. Geographical Differences Associated with Single-Nucleotide Polymorphisms (SNPs) in Nine Gene Targets among Resistant Clinical Isolates of Mycobacterium tuberculosis
  84. Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova
  85. Periodontal Disease Is an Independent Predictor of Intracardiac Calcification
  86. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country
  87. Middle‐of‐the‐night PCI does not affect subsequent day PCI success and complication rates by the same operator
  88. First Evaluation of an Improved Assay for Molecular Genetic Detection of Tuberculosis as Well as Rifampin and Isoniazid Resistances
  89. Complications related to access site after percutaneous coronary interventions
  90. Can total cardiac calcium predict the coronary calcium score?
  91. Assessment Of The Nosocomial Transmission Of MDR TB In Moldova Using DNA Fingerprinting Of M.tuberculosis
  92. Relationship between intensive diuresis and QRS morphology change
  93. Increasing tuberculosis case detection: lessons from the Republic of Moldova